Nosipho Ngubane - Publications

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.

Journal: The Lancet. Respiratory medicine

Published: March 18, 2024

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: December 18, 2023

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.

Journal: The New England journal of medicine

Published: December 22, 2022

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.

Journal: The New England journal of medicine

Published: September 02, 2022

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.

Journal: Lancet (London, England)

Published: August 26, 2022

Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 07, 2021

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: May 29, 2021

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.

Journal: BMJ open

Published: October 11, 2020

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.

Journal: The New England journal of medicine

Published: March 05, 2020

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.

Journal: The New England journal of medicine

Published: March 14, 2019